0 comments

mobile_photo

Four New Drug Added to CredibleMeds® Lists and Mobile Apps for QTdrugs/DTA Lists

View Post


1 comment

mobile_photo

Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of these changes to the QTdrugs.org lists: 1. Add Ribociclib and Necitumumab to Possible Risk List 2. Remove Foscarnet from Possible Risk List

View Post

0 comments

mobile_photo

The following changes have been made to the CredibleMed's lists of drugs:

View Post

0 comments

mobile_photo

Following the successful launch of the app, Cardiology Today recently published an article in their newest edition featuring the new mobile offering for patients and healthcare providers, written by Dr. Ray Woosley, Founder of CredibleMeds.

View Post

0 comments

mobile_photo

Pilsicainide, terodiline, prothipendyl and ketanserin added to QTdrugs lists. Smartphone Apps available FREE.

View Post

7 comments

mobile_photo

AZCERT is pleased to announce that Smartphone Apps are now available at no cost in the Apple, Windows Mobile and Google App Stores

View Post

0 comments

mobile_photo

AZCERT is pleased to announce that Smartphone Apps are now available at no cost in the Apple and Google App Stores for the CredibleMeds lists of drugs that prolong QT.

View Post

1 comment

mobile_photo

Changes to QTdrugs lists: Olanzapine, droxidopa, melperone, romidepsin, bendamustine and terlipressin

View Post

0 comments

Donate to Support QTdrugs Lists

View Post